EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger Series B Preferred Stock investment made in Pulmatrix with a conversion price of $2.20 is a part of the ongoing merger process Framingham, Mass., April 21, 2026 - Pulmatrix, Inc. (“Pulmatrix” or the “Company”) (Nasdaq: PULM), today announced the closing of its previously announced private placement of Series B Convertible Preferred Stock (“Series B Preferred Stock”) with an affiliate of Eos SENOLYTIX, Inc. (“Eos”), which such transaction is a part of its planned merger with Eos. The Series B Preferred Stock is convertible into common stock at a price per share of $2.20. The aggregate gross proceeds to the Company from the offering were approximately $1 million, before deducting offering expenses payable by the Company. The Company currently intends to use the permitted net proceeds from the offering for working capital and other general corporate purposes. Peter Ludlum, Interim Chief Executive Officer of Pulmatrix, commented, “We have taken an important initial step forward as part of the planned merger and are pleased that investors supporting Eos…
Open exhibit ↗Current Report · Items 7.01, 8.01, 9.01 · 8-K
Pulmatrix, Inc.
PULMNASDAQEQUITYCurrent
Regulation FD Disclosure · Other Events
Item 7.01 Regulation FD Disclosure. On April 21, 2026, Pulmatrix, Inc. (the “Company”) issued a press release announcing the closing of the Private Placement (as defined herein). A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.…
Disclosure sections
Item 7.01Item 7.01 - Regulation FD Disclosure
Item
7.01 Regulation FD Disclosure.
On
April 21, 2026, Pulmatrix, Inc. (the “Company”) issued a press release announcing the closing of the Private
Placement (as defined herein). A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.
The
information in this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) is being furnished pursuant to Item 7.01 and
shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange
Act ”), or otherwise be subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference
in any filing under the Securities Act of 1933, as amended (the “ Securities Act ”), or the Exchange Act, whether
made before or after the date hereof and regardless of any general incorporation language in such filing.
Item 8.01Item 8.01 - Other Events
Item
8.01 Other Events
On
April 16, 2026, the Company closed its previously announced private placement of its Series B Preferred Stock, par value $0.0001 per
share (the “ Private Placement ”). The Private Placement was exempt from the registration requirements of the
Securities Act pursuant to the exemption for transactions by an issuer not involving any public offering under Section 4(a)(2) of the
Securities Act and Rule 506 of Regulation D of the Securities Act and in reliance on similar exemptions under applicable state laws.